Leptin/lipopolysaccharide-treated dendritic cell vaccine improved cellular immune responses in an animal model of breast cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Guanghui R, Xiaoyan H, Shuyi Y, et al. An efficient or methodical review of immunotherapy against breast cancer. J Biochem Mol Toxicol. 2019;33(8):e22339. doi: 10.1002/jbt.22339.
   PubMed Web of Science ®Google Scholar
• Gu-Trantien C, Loi S, Garaud S, et al. CD4+ follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest. 2013;123(7):2873–2892. doi: 10.1172/JCI67428.
   PubMed Web of Science ®Google Scholar
• Li L, Wang W, Pan H, et al. Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer. J Transl Med. 2017;15(1):23. doi: 10.1186/s12967-017-1124-9.
   PubMed Web of Science ®Google Scholar
• Raphael I, Nalawade S, Eagar TN, et al. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74(1):5–17. doi: 10.1016/j.cyto.2014.09.011.
   PubMed Web of Science ®Google Scholar
• Golstein P, Griffiths GM. An early history of T cell-mediated ­cytotoxicity. Nat Rev Immunol. 2018;18(8):527–535. doi: 10.1038/s41577-018-0009-3.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807–821. doi: 10.1038/s41423-020-0488-6.
   PubMed Web of Science ®Google Scholar
• Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol. 2005;5(4):296–306. doi: 10.1038/nri1592.
   PubMed Web of Science ®Google Scholar
• Castell-Rodríguez A, Piñón-Zárate G, Herrera-Enríquez M, et al. Dendritic cells: location, function, and clinical implications. In: Ghosh A, editor. Biology of myelomonocytic cells. London, UK: IntechOpen; 2017. p. 21–50.
   Google Scholar
• Mastelic-Gavillet B, Balint K, Boudousquie C, et al. Personalized dendritic cell vaccines – recent breakthroughs and encouraging clinical results. Front Immunol. 2019;10:766. doi: 10.3389/fimmu.2019.00766.
   PubMed Web of Science ®Google Scholar
• Ardavín C, Amigorena S, Reis e Sousa C. Dendritic cells: immunobiology and cancer immunotherapy. Immunity. 2004;20(1):17–23. doi: 10.1016/s1074-7613(03)00352-2.
   PubMedGoogle Scholar
• Becerril S, Rodríguez A, Catalán V, et al. Functional relationship between leptin and nitric oxide in metabolism. Nutrients. 2019;11(9):2129. doi: 10.3390/nu11092129.
   PubMed Web of Science ®Google Scholar
• Mattioli B, Straface E, Quaranta MG, et al. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol. 2005;174(11):6820–6828. doi: 10.4049/jimmunol.174.11.6820.
   PubMed Web of Science ®Google Scholar
• Francisco V, Pino J, Gonzalez-Gay MA, et al. Adipokines and inflammation: is it a question of weight? Br J Pharmacol. 2018;175(10):1569–1579. doi: 10.1111/bph.14181.
   PubMed Web of Science ®Google Scholar
• Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med. 2012;33(1):35–45. doi: 10.1016/j.mam.2011.10.012.
   PubMed Web of Science ®Google Scholar
• Abella V, Scotece M, Conde J, et al. Leptin in the interplay of inflammation, metabolism and immune system disorders. Nat Rev Rheumatol. 2017;13(2):100–109. doi: 10.1038/nrrheum.2016.209.
   PubMed Web of Science ®Google Scholar
• Mattioli B, Straface E, Matarrese P, et al. Leptin as an immunological adjuvant: enhanced migratory and CD8+ T cell stimulatory capacity of human dendritic cells exposed to leptin. FASEB J. 2008;22(6):2012–2022. doi: 10.1096/fj.07-098095.
   PubMed Web of Science ®Google Scholar
• Naylor C, Petri WA. Leptin regulation of immune responses. Trends Mol Med. 2016;22(2):88–98. doi: 10.1016/j.molmed.2015.12.001.
   PubMed Web of Science ®Google Scholar
• White SJ, Taylor MJ, Hurt RT, et al. Leptin-based adjuvants: an innovative approach to improve vaccine response. Vaccine. 2013;31(13):1666–1672. doi: 10.1016/j.vaccine.2013.01.032.
   PubMed Web of Science ®Google Scholar
• Masoumi J, Jafarzadeh A, Tavakoli T, et al. Inhibition of apelin/APJ axis enhances the potential of dendritic cell-based vaccination to modulate TH1 and TH2 cell-related immune responses in an animal model of metastatic breast cancer. Adv Med Sci. 2022;67(1):170–178. doi: 10.1016/j.advms.2022.02.006.
   PubMed Web of Science ®Google Scholar
• Balog JÁ, Hackler LJr, Kovács AK, et al. Single cell mass cytometry revealed the immunomodulatory effect of cisplatin via downregulation of splenic CD44+, IL-17A+ MDSCs and promotion of circulating IFN-γ+ myeloid cells in the 4T1 metastatic breast cancer model. Int J Mol Sci. 2019;21(1):170. doi: 10.3390/ijms21010170.
   PubMed Web of Science ®Google Scholar
• Jadidi-Niaragh F, Atyabi F, Rastegari A, et al. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice. J Control Release. 2017;246:46–59. doi: 10.1016/j.jconrel.2016.12.012.
   PubMed Web of Science ®Google Scholar
• Basu A, Albert GK, Awshah S, et al. Identification of immunogenic MHC class II human HER3 peptides that mediate anti-HER3 CD4+ Th1 responses and potential use as a cancer vaccine. Cancer Immunol Res. 2022;10(1):108–125. doi: 10.1158/2326-6066.CIR-21-0454.
   PubMed Web of Science ®Google Scholar
• Zhang R, Yuan F, Shu Y, et al. Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models. Cancer Immunol Immunother. 2020;69(1):135–145. doi: 10.1007/s00262-019-02448-z.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang Y, Miao L, et al. Combination immunotherapy of MUC1 mRNA nano-vaccine and CTLA-4 blockade effectively inhibits growth of triple negative breast cancer. Mol Ther. 2018;26(1):45–55. doi: 10.1016/j.ymthe.2017.10.020.
   PubMed Web of Science ®Google Scholar
• Yazdani M, Gholizadeh Z, Nikpoor AR, et al. Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy. Sci Rep. 2021;11(1):14661. doi: 10.1038/s41598-021-94250-0.
   PubMed Web of Science ®Google Scholar
• Wculek SK, Amores-Iniesta J, Conde-Garrosa R, et al. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen. J Immunother Cancer. 2019;7(1):100. doi: 10.1186/s40425-019-0565-5.
   PubMedGoogle Scholar
• Özverel CS, Uyanikgil Y, Karaboz İ, et al. Investigation of the combination of anti-PD-L1 mAb with HER2/neu-loaded dendritic cells and QS-21 saponin adjuvant: effect against HER2 positive breast cancer in mice. Immunopharmacol Immunotoxicol. 2020;42(4):346–357. doi: 10.1080/08923973.2020.1775644.
   PubMed Web of Science ®Google Scholar
• Tan C, Reddy V, Dannull J, et al. Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model. J Transl Med. 2013;11(1):148. doi: 10.1186/1479-5876-11-148.
   PubMedGoogle Scholar
• Zhang SN, Choi IK, Huang JH, et al. Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF. Mol Ther. 2011;19(8):1558–1568. doi: 10.1038/mt.2011.29.
   PubMed Web of Science ®Google Scholar
• Hahn T, Alvarez I, Kobie JJ, et al. Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer. Int J Cancer. 2006;118(9):2220–2231. doi: 10.1002/ijc.21616.
   PubMed Web of Science ®Google Scholar
• Baldo BA. Immune- and non-immune-mediated adverse effects of monoclonal antibody therapy: a survey of 110 approved antibodies. Antibodies (Basel). 2022;11(1):17–58. doi: 10.3390/antib11010017.
   PubMedGoogle Scholar
• Saffari F, Jafarzadeh A. Development of anti-rituximab antibodies in rituximab-treated patients: related parameters and consequences. Indian J Med Res. 2022;155(3 and 4):335–346. doi: 10.4103/ijmr.IJMR_312_19.
   PubMed Web of Science ®Google Scholar
• Lam QLK, Liu S, Cao X, et al. Involvement of leptin signaling in the survival and maturation of bone marrow-derived dendritic cells. Eur J Immunol. 2006;36(12):3118–3130. doi: 10.1002/eji.200636602.
   PubMed Web of Science ®Google Scholar
• Li J, Yao Q, Liu D. Hydrodynamic cell delivery for simultaneous establishment of tumor growth in mouse lung, liver and kidney. Cancer Biol Ther. 2011;12(8):737–741. doi: 10.4161/cbt.12.8.16442.
   PubMed Web of Science ®Google Scholar
• Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol. 2001;Chapter 20(1):Unit 20.2. doi: 10.1002/0471142735.im2002s39.
   PubMedGoogle Scholar
• Moraes-Vieira PM, Larocca RA, Bassi EJ, et al. Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells. Eur J Immunol. 2014;44(3):794–806. doi: 10.1002/eji.201343592.
   PubMed Web of Science ®Google Scholar
• Macia L, Delacre M, Abboud G, et al. Impairment of dendritic cell functionality and steady-state number in obese mice. J Immunol. 2006;177(9):5997–6006. doi: 10.4049/jimmunol.177.9.5997.
   PubMed Web of Science ®Google Scholar
• Khalife E, Khodadadi A, Talaeizadeh A, et al. Overexpression of regulatory T Cell-Related markers (FOXP3, CTLA-4 and GITR) by peripheral blood mononuclear cells from patients with breast cancer. Asian Pac J Cancer Prev. 2018;19(11):3019–3025. doi: 10.31557/APJCP.2018.19.11.3019.
   PubMedGoogle Scholar
• Fernández-Riejos P, Najib S, Santos-Alvarez J, et al. Role of leptin in the activation of immune cells. Mediators Inflamm. 2010;2010:568343–568348. doi: 10.1155/2010/568343.
   PubMed Web of Science ®Google Scholar
• Lord GM, Matarese G, Howard JK, et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998;394(6696):897–901. doi: 10.1038/29795.
   PubMed Web of Science ®Google Scholar
• Batra A, Okur B, Glauben R, et al. Leptin: a critical regulator of CD4+ T-cell polarization in vitro and in vivo. Endocrinology. 2010;151(1):56–62. doi: 10.1210/en.2009-0565.
   PubMed Web of Science ®Google Scholar
• Sheikhi A, Jafarzadeh A, Kokhaei P, et al. Whole tumor cell vaccine adjuvants: comparing IL-12 to IL-2 and IL-15. Iran J Immunol. 2016;13(3):148–166.
   PubMed Web of Science ®Google Scholar
• Jafarzadeh A, Larussa T, Nemati M, et al. T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection. Microb Pathog. 2018;116:227–236. doi: 10.1016/j.micpath.2018.01.040.
   PubMed Web of Science ®Google Scholar
• Tomasicchio M, Semple L, Esmail A, et al. An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells. Cancer Immunol Immunother. 2019;68(1):71–83. doi: 10.1007/s00262-018-2238-5.
   PubMed Web of Science ®Google Scholar
• Qi C-J, Ning Y-L, Han Y-S, et al. Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer. Cancer Immunol Immunother. 2012;61(9):1415–1424. doi: 10.1007/s00262-011-1192-2.
   PubMed Web of Science ®Google Scholar
• Saucillo DC, Gerriets VA, Sheng J, et al. Leptin metabolically licenses T cells for activation to link nutrition and immunity. J Immunol. 2014;192(1):136–144. doi: 10.4049/jimmunol.1301158.
   PubMed Web of Science ®Google Scholar
• Rescigno M, Martino M, Sutherland CL, et al. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med. 1998;188(11):2175–2180. doi: 10.1084/jem.188.11.2175.
   PubMed Web of Science ®Google Scholar
• Kaisho T, Takeuchi O, Kawai T, et al. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol. 2001;166(9):5688–5694. doi: 10.4049/jimmunol.166.9.5688.
   PubMed Web of Science ®Google Scholar
• Verhasselt V, Buelens C, Willems F, et al. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. Journal of Immunology (Baltimore, Md: 1950). 1997;158(6):2919–2925. doi: 10.4049/jimmunol.158.6.2919.
   PubMed Web of Science ®Google Scholar
• Kalaiyarasu S, Bhatia S, Mishra N, et al. Elevated level of pro inflammatory cytokine and chemokine expression in chicken bone marrow and monocyte derived dendritic cells following LPS induced maturation. Cytokine. 2016;85:140–147. doi: 10.1016/j.cyto.2016.06.022.
   PubMed Web of Science ®Google Scholar
• Xu L, Kwak M, Zhang W, et al. Time-dependent effect of E. coli LPS in spleen DC activation in vivo: alteration of numbers, expression of co-stimulatory molecules, production of pro-inflammatory cytokines, and presentation of antigens. Mol Immunol. 2017;85:205–213. doi: 10.1016/j.molimm.2017.02.017.
   PubMed Web of Science ®Google Scholar
• Showalter LE, Czerniecki BJ, Kodumudi K, et al. Murine dendritic cells grown in Serum-Free culture show potent therapeutic activity when loaded with novel Th epitopes in an orthotopic model of HER2pos breast cancer. Vaccines (Basel). 2021;9(9):1037. doi: 10.3390/vaccines9091037.
   PubMed Web of Science ®Google Scholar
• Czerniecki BJ, Koski GK, Koldovsky U, et al. Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res. 2007;67(4):1842–1852. doi: 10.1158/0008-5472.CAN-06-4038.
   PubMed Web of Science ®Google Scholar